These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26669528)

  • 21. Use and misuse of opioid replacement therapies: a Queensland study.
    Smirnov A; Kemp R
    Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analgesic management of acute pain in patients receiving methadone or buprenorphine].
    Zinck L; Sonne NM; Madsen SL; Nikolajsen L
    Ugeskr Laeger; 2015 Mar; 177(10):. PubMed ID: 25749118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methadone and Buprenorphine for Opioid Dependence During Pregnancy: A Retrospective Cohort Study: Re: Meyer et al.
    McCarthy JJ
    J Addict Med; 2016; 10(2):133-4. PubMed ID: 26985649
    [No Abstract]   [Full Text] [Related]  

  • 24. Medical specialty of buprenorphine prescribers for pregnant women with opioid use disorder.
    Hollander MAG; Jarlenski MP; Donohue JM; Cole ES; Kelley D; Krans EE
    Am J Obstet Gynecol; 2019 May; 220(5):502-503. PubMed ID: 30703340
    [No Abstract]   [Full Text] [Related]  

  • 25. Observations on the effects of buprenorphine and methadone on illicit drug use.
    Pesce AJ; Tran K; Krock K; Cua A; Thomas R
    J Opioid Manag; 2024; 20(3):193-195. PubMed ID: 39017611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discontinuing Methadone and Buprenorphine: A Review and Clinical Challenges.
    Zweben JE; Sorensen JL; Shingle M; Blazes CK
    J Addict Med; 2021 Nov-Dec 01; 15(6):454-460. PubMed ID: 33323695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innovations in efforts to expand treatment for opioid use disorder.
    Sigmon SC
    Prev Med; 2019 Nov; 128():105818. PubMed ID: 31445112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of non-compliant buprenorphine, levomethadone, and methadone use among opioid dependent persons in treatment.
    Casati A; Piontek D; Pfeiffer-Gerschel T
    Subst Abuse Treat Prev Policy; 2014 May; 9():19. PubMed ID: 24885218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Commentary on Nolan et al. (2014): Opiate substitution treatment and hepatitis C virus prevention: building an evidence base?
    Vickerman P; Page K; Maher L; Hickman M
    Addiction; 2014 Dec; 109(12):2060-1. PubMed ID: 25384936
    [No Abstract]   [Full Text] [Related]  

  • 30. Opioids and Opioid Use Disorder in Pregnancy.
    Sanjanwala AR; Lim G; Krans EE
    Obstet Gynecol Clin North Am; 2023 Mar; 50(1):229-240. PubMed ID: 36822706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Opioid Substitution Treatment in Prisons: Comparison of Cost of Buprenorphine Depot with other Medications - a Health-Economic Calculation].
    Stöver H; Keppler K
    Gesundheitswesen; 2023 Jun; 85(6):573-577. PubMed ID: 35921849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential for Precision Medicine in Methadone Treatment of Opioid Use Disorder.
    Saxon AJ
    J Addict Med; 2020; 14(5):362-363. PubMed ID: 32058338
    [No Abstract]   [Full Text] [Related]  

  • 33. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of Opioid Overdose.
    Babu KM; Brent J; Juurlink DN
    N Engl J Med; 2019 Jun; 380(23):2246-2255. PubMed ID: 31167053
    [No Abstract]   [Full Text] [Related]  

  • 35. Medication-assisted therapy for opioid-dependent incarcerated populations in New Mexico: statewide efforts to increase access.
    Trigg BG; Dickman SL
    Subst Abus; 2012; 33(1):76-84. PubMed ID: 22263716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A truly patient-centred evaluation of opioid agonist treatment.
    Trujols J; Vicent-Gil M; Duran-Sindreu S; Portella MJ
    Lancet Psychiatry; 2023 Aug; 10(8):583. PubMed ID: 37479338
    [No Abstract]   [Full Text] [Related]  

  • 37. A mixed-methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine in community-based care in England and Wales.
    Gibson R; MacLeod N; Donaldson LJ; Williams H; Hibbert P; Parry G; Bhatt J; Sheikh A; Carson-Stevens A
    Addiction; 2020 Nov; 115(11):2066-2076. PubMed ID: 32149443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buprenorphine uptake during pregnancy following the 2017 guidelines update on prenatal opioid use disorder.
    Nguemeni Tiako MJ; Meinhofer A; Friedman A; South EC; Epstein RL; Meisel ZF; Morgan JR
    Am J Obstet Gynecol; 2022 Sep; 227(3):544-546.e1. PubMed ID: 35613648
    [No Abstract]   [Full Text] [Related]  

  • 39. Utilization of buprenorphine and methadone among opioid users who inject drugs.
    Tsui JI; Burt R; Thiede H; Glick SN
    Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Micro-dosing Intravenous Buprenorphine to Rapidly Transition From Full Opioid Agonists.
    Thakrar AP; Jablonski L; Ratner J; Rastegar DA
    J Addict Med; 2022 Jan-Feb 01; 16(1):122-124. PubMed ID: 33758112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.